Hepatocellular carcinoma surveillance in a western population with hepatitis B

Jennifer Urquhart, Jonathan M. Schwartz

Research output: Contribution to journalArticle

Abstract

Hepatocellular carcinoma (HCC) is a malignant tumor arising primarily in cirrhotic livers as a consequence of chronic hepatitis B or C virus infection or alcohol-induced cirrhosis. Unlike the majority of other common cancer types, the incidence of HCC in the United States is still rising, with peak incidence expected for 2020. Although hepatitis B is a less common etiology for the development of HCC in the West, it is the most common risk factor among certain ethnic groups in the United States. Given the high case fatality of HCC, surveillance efforts have been recommended. Specifically, HCC surveillance has demonstrated a survival benefit in patients with chronic hepatitis B. In this review, we discuss the demographics of patients with HCC in the United States, the evidence promoting surveillance, and recent literature identifying the best surveillance test.

Original languageEnglish (US)
Pages (from-to)147-152
Number of pages6
JournalCurrent Hepatitis Reports
Volume10
Issue number2
DOIs
StatePublished - Jun 1 2011
Externally publishedYes

Keywords

  • Hepatitis B
  • Hepatocellular carcinoma
  • Serum α-fetoprotein
  • Surveillance
  • Ultrasound

ASJC Scopus subject areas

  • Hepatology
  • Virology

Fingerprint Dive into the research topics of 'Hepatocellular carcinoma surveillance in a western population with hepatitis B'. Together they form a unique fingerprint.

  • Cite this